Učitavanje...
A96 ADALIMUMAB FOR MAINTENANCE OF REMISSION IN CROHN’S DISEASE
BACKGROUND: Maintenance of remission of Crohn’s disease (CD) is a clinically important goal, as disease relapse can negatively affect quality of life. AIMS: The objective of this systematic review was to assess the efficacy and safety of adalimumab for maintenance of remission in patients with quies...
Spremljeno u:
| Izdano u: | J Can Assoc Gastroenterol |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6512699/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz006.095 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|